Calvin Goforth, PhD

Calvin Goforth, PhD
Calvin Goforth, PhD, VIC Founder and Chief Executive Officer, has extensive experience in start-up company development in founder, investor, board member, and executive roles. His experience encompasses intellectual property assessment, building strong development teams, raising private investment and government funding, and bringing products to market. He received a BS in Aerospace Engineering with Highest Honors from the University of Texas at Austin.
Find me on:

Recent Posts

Zero Federal Capital Gains Taxes on High Return Investments

With a new administration comes new perspectives and likely changes in tax policy. President Biden has proposed doubling the rate that wealthy Americans pay on investment capital gains up to 43.4%, a topic that has been...

Protecting Early Investors in Capital-Intensive Life Science Companies

Angel investors often invest at the seed stage of a company's development. The typically smaller round sizes and lower valuations allow early individual investors to gain a meaningful stake in a given company. However,...

A Letter from our CEO

When I wrote my last “letter from the CEO” in January 2020, I did not foresee the tumultuous year ahead. For so many, it’s been a tragic and difficult year on a personal level. We have all been impacted by the pandemic...

VIC Investor Network Introduces a Secondary Market for Members

Provides VIN Members Early Liquidity Options FAYETTEVILLE, AR. DECEMBER 14, 2020- The VIC Investor Network (“VIN”) makes investments into companies based on technologies that can have substantial impact on human health...

VIC Foundry: An Incubator for High Impact Life Science Technologies

What is VIC Foundry? VIC Foundry is one element of the VIC innovation ecosystem. It develops technologies sourced from top research institutions in the U.S. with the potential to have substantial impact and commercial...

VIC 2020 Mid-Year Update

So far, in 2020, VIC’s portfolio of companies reached numerous milestones and potential business partners are increasingly finding ways to re-engage in spite of the ongoing pandemic. The VIC Foundry has expanded...

Why VIC Sometimes Steps Outside Its Life Science Focus

VIC Technology Venture Development primarily is focused on building companies around high-impact life science technologies, including medical devices, therapeutics, diagnostics, and advanced instrumentation. More than...

VIC 2019 Annual Report

In the past year, VIC’s portfolio of companies reached numerous milestones, the VIC Investor Network (VIN) experienced its first exit, and we added important new elements to the VIC ecosystem. While progress in 2019 was...

A Letter from our CEO

Welcome to the 20s! To my ears, 2020 sounds very futuristic – but we are living it. The pace of technological change continues to accelerate and have profound impact on all of us. VIC’s motto is Technology Solutions for...

White Paper: Avoiding Herd Mentality - Sourcing Quality Innovation Beyond The VC Hot Zones

Twenty years ago, a two-bedroom apartment in the heart of Silicon Valley would cost an entrepreneur $1,600 a month1. Today, the same apartment would go for $4,000 per month or more. The cost of living and doing business...

FEATURED RESOURCES

News
Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion
White Paper
Portfolio Diversification in Times of Market Volatility
Case Study
The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World
Updates
VIC 2020 Annual Report Executive Summary
News
CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software
Case Study
Opportunity Assessment: How To Vet So Much Tech
Interview
Inside CU Innovations: An Interview with Executive Director, Kim Muller
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
Updates
VIC Technology Venture Development Announces New Board of Directors Appointment
News
VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries
Interview
VIC Fellows Spotlight: Travis Nemkov, PhD
From The Corner Office
Vixiar: Solving a Big Problem With a Small Device